| hexitol dehydrogenase activity |
| hexitol formation |
| hexitol metabolic process |
| hexitol metabolism |
| hexitol synthesis |
| hexitolbiphosphate |
| HEXMF |
| HexMF protocol |
| HEXNAC TRANSFERASES |
| HEXO |
| Hexobarbital |
| Hexobarbital [Chemical/Ingredient] |
| Hexobarbital [Mass/volume] in Serum or Plasma |
| Hexobarbital [Mass/volume] in Urine |
| HEXOBARBITAL @ 250MG @ TABLET |
| Hexobarbital | bld-ser-plas |
| Hexobarbital | urine |
| Hexobarbital 250 MG |
| Hexobarbital 250 MG Oral Tablet |
| HEXOBARBITAL 250MG ORAL TABLET |
| HEXOBARBITAL 250MG TAB |
| HEXOBARBITAL 250MG TAB [VA Product] |
| HEXOBARBITAL 250MG TABLET |
| Hexobarbital 260 MG |
| Hexobarbital 260 MG [Pre Sed] |
| Hexobarbital 260 MG Oral Tablet |
| Hexobarbital 260 MG Oral Tablet [Pre Sed] |
| HEXOBARBITAL 260 MG ORAL TABLET [PRE] |
| Hexobarbital 260mg |
| Hexobarbital 260mg (product) |
| HEXOBARBITAL 260MG TAB |
| HEXOBARBITAL 260MG TAB [VA Product] |
| hexobarbital hydroxylase |
| Hexobarbital Oral Tablet |
| Hexobarbital Oral Tablet [Pre Sed] |
| hexobarbital oxidase |
| Hexobarbital SerPl-mCnc |
| HEXOBARBITAL SODIUM |
| Hexobarbital Ur-mCnc |
| Hexobarbital, Sodium |
| Hexobarbital:Mass Concentration:Point in time:Serum/Plasma:Quantitative |
| Hexobarbital:Mass Concentration:Point in time:Urine:Quantitative |
| Hexobarbital:MCnc:Pt:Ser/Plas:Qn |
| Hexobarbital:MCnc:Pt:Urine:Qn |
| [email protected]@[email protected] |
| Hexobarbitone |
| Hexobendine |
| Hexobendine [Chemical/Ingredient] |
| Hexobendine 20 MG |
| Hexobendine 60 MG |
| Hexobendine hydrochloride |
| hexocalex |
| hexocalex 6-9 |
| hexociclium |
| hexocyclium |
| hexocyclium 25 MG |
| hexocyclium 25 MG Oral Tablet |
| hexocyclium 50 MG |
| hexocyclium 50 MG Extended Release Tablet |
| hexocyclium Extended Release Tablet |
| Hexocyclium methylsulfate |
| HEXOCYCLIUM METHYLSULFATE @ 25MG @ TABLET |
| HEXOCYCLIUM METHYLSULFATE @ 50MG @ TABLET, SUSTAINED ACTION |
| HEXOCYCLIUM METHYLSULFATE 25MG ORAL TABLET |
| HEXOCYCLIUM METHYLSULFATE 25MG TAB |
| HEXOCYCLIUM METHYLSULFATE 25MG TAB [VA Product] |
| HEXOCYCLIUM METHYLSULFATE 25MG TABLET |
| HEXOCYCLIUM METHYLSULFATE 50MG ORAL TABLET, SUSTAINED ACTION |
| HEXOCYCLIUM METHYLSULFATE 50MG TAB,SA |
| HEXOCYCLIUM METHYLSULFATE 50MG TAB,SA [VA Product] |
| HEXOCYCLIUM METHYLSULFATE 50MG TABLET, SUSTAINED ACTION |
| Hexocyclium Methylsulfate Tab 25 MG |
| HEXOCYCLIUM [email protected]@[email protected] |
| HEXOCYCLIUM [email protected]@[email protected], SUSTAINED ACTION |
| hexocyclium Oral Tablet |
| Hexogen |
| HEXOH-benzisoquinoline |
| hExoI |
| HEXOKINASE |
| hexokinase (phosphorylating) |
| Hexokinase [Chemical/Ingredient] |
| Hexokinase [Enzymatic activity/mass] in Red Blood Cells |
| Hexokinase [Enzymatic activity/volume] in Plasma |
| Hexokinase [Enzymatic activity/volume] in Red Blood Cells |
| Hexokinase [Presence] in Plasma |
| Hexokinase | bld-ser-plas |
| Hexokinase | red blood cells |
| Hexokinase 1 |
| Hexokinase 1 [Enzymatic activity/volume] in Red Blood Cells |
| Hexokinase 1 | red blood cells |
| hexokinase 1 protein, mouse |
| hexokinase 1, human |
| Hexokinase 1:Catalytic Concentration:Point in time:Erythrocytes:Quantitative |
| Hexokinase 1:CCnc:Pt:RBC:Qn |
| Hexokinase 1/Hexokinase.total |
| Hexokinase 1/Hexokinase.total in Red Blood Cells |
| Hexokinase 1/Hexokinase.total:Catalytic Fraction:Point in time:Erythrocytes:Quantitative |
| Hexokinase 1/Hexokinase.total:CFr:Pt:RBC:Qn |
| Hexokinase 2 |
| Hexokinase 2 Gene |
| hexokinase 2 pseudogene |
| Hexokinase 2 wt Allele |
| hexokinase 2, Arabidopsis |
| Hexokinase 3 |
| hexokinase 3 (white cell) |
| Hexokinase 3 [Enzymatic activity/volume] in Red Blood Cells |
| Hexokinase 3 | red blood cells |
| Hexokinase 3:Catalytic Concentration:Point in time:Erythrocytes:Quantitative |
| Hexokinase 3:CCnc:Pt:RBC:Qn |
| Hexokinase 3/Hexokinase.total |
| Hexokinase 3/Hexokinase.total in Red Blood Cells |
| Hexokinase 3/Hexokinase.total:Catalytic Fraction:Point in time:Erythrocytes:Quantitative |
| Hexokinase 3/Hexokinase.total:CFr:Pt:RBC:Qn |
| HEXOKINASE 4 |
| Hexokinase A |
| hexokinase activity |
| Hexokinase D |
| Hexokinase deficiency anemia |
| HEXOKINASE DEFICIENCY HEMOLYTIC ANEMIA |
| HEXOKINASE DEFICIENCY HEMOLYTIC ANEMIA, 96-BP DEL |
| HEXOKINASE DEFICIENCY HEMOLYTIC ANEMIA, LEU529SER |
| hexokinase domain containing 1 |
| hexokinase HXK1, Arabidopsis |
| Hexokinase II |
| Hexokinase isoenzyme 2, S cerevisiae |
| hexokinase IV |
| hexokinase Melzo |
| HEXOKINASE OF SPERMATOZOA |
| Hexokinase Plas Ql |
| Hexokinase Plas-cCnc |
| Hexokinase RBC-cCnc |
| Hexokinase RBC-cCnt |
| hexokinase type I activity |
| hexokinase type II activity |
| hexokinase type III activity |
| hexokinase type IV |
| hexokinase type IV (glucokinase) activity |
| hexokinase type IV glucokinase activity |
| Hexokinase-2, Muscle |
| hexokinase-dependent signaling |
| hexokinase-dependent signalling |
| hexokinase-independent signaling |
| hexokinase-independent signalling |
| hexokinase-like protein, Emericella nidulans |
| HEXOKINASE, GLUCOSE |
| Hexokinase, Type II |
| HEXOKINASE, WHITE CELL |
| Hexokinase:ACnc:Pt:Plas:Ord |
| Hexokinase:Arbitrary Concentration:Point in time:Plasma:Ordinal |
| Hexokinase:Catalytic Concentration:Point in time:Erythrocytes:Quantitative |
| Hexokinase:Catalytic Concentration:Point in time:Plasma:Quantitative |
| Hexokinase:Catalytic Content:Point in time:Erythrocytes:Quantitative |
| Hexokinase:CCnc:Pt:Plas:Qn |
| Hexokinase:CCnc:Pt:RBC:Qn |
| Hexokinase:CCnt:Pt:RBC:Qn |
| Hexokinase.total |
| Hexokinase1 Fr RBC |
| Hexokinase1 RBC-cCnc |
| Hexokinase3 Fr RBC |
| Hexokinase3 RBC-cCnc |
| hexolame |
| Hexom |
| Hexomedin |
| Hexomedin N |
| Hexomedine |
| Hexomyza |
| Hexomyza schineri |
| Hexomyza schineri (Giraud, 1861) |
| Hexon |
| hexon binding |
| hexon capsid protein, Adenovirus |
| hexon protein, Adenovirus |
| Hexonamide, 4-amino-4,5,6-trideoxy-N-(1-(3,4-dihydro-8-hydroxy-1-oxo-1H-2-benzopyran-3-yl)-3-methylbutyl)-5-methyl- |
| hexonate dehydrogenase |
| Hexonium |
| Hexonium Diiodide |
| Hexopal |
| Hexopal Forte |
| Hexopal Forte 750 MG Oral Tablet |
| hexophilin A3 |
| Hexoprenaline |
| Hexoprenaline [Chemical/Ingredient] |
| Hexoprenaline 0.0025 MG/ML |
| Hexoprenaline 0.0025 MG/ML Injectable Solution |
| Hexoprenaline 0.005 MG/ML |
| Hexoprenaline 0.005 MG/ML Injectable Solution |
| Hexoprenaline 0.025 MG/ML |
| Hexoprenaline 0.025 MG/ML Oral Solution |
| Hexoprenaline 0.1 MG/ACTUAT |
| Hexoprenaline 0.1 MG/ACTUAT Inhalant Solution |
| Hexoprenaline 0.25 MG/ML |
| Hexoprenaline 0.25 MG/ML Inhalant Solution |
| Hexoprenaline 0.5 MG |
| Hexoprenaline 0.5 MG Oral Tablet |
| Hexoprenaline 0.5 MG Sublingual Tablet |
| Hexoprenaline 1 MG |
| Hexoprenaline 1 MG Oral Tablet |
| HEXOPRENALINE HCL @ 0.125MG/5 @ SYRUP |
| HEXOPRENALINE HCL @ 0.25MG/ML @ SOLUTION, NON-ORAL |
| HEXOPRENALINE HCL 0.125MG/5 SYRUP |
| HEXOPRENALINE HCL 0.25MG/ML SOLUTION, NON-ORAL |
| Hexoprenaline HCl Soln Nebu 0.25 MG/ML |
| Hexoprenaline HCl Syrup 0.125 MG/5ML |
| Hexoprenaline Inhalant Solution |
| Hexoprenaline Injectable Solution |
| Hexoprenaline Oral Solution |
| Hexoprenaline Oral Tablet |
| Hexoprenaline Sublingual Tablet |
| Hexoprenaline Sulfate |
| HEXOPRENALINE SULFATE @ 0.1MG @ AEROSOL W/ADAPTER (GM) |
| HEXOPRENALINE SULFATE @ 0.5MG @ TABLET |
| HEXOPRENALINE SULFATE @ 1MG @ TABLET |
| HEXOPRENALINE SULFATE @ 2.5MCG/ML @ AMPUL (ML) |
| HEXOPRENALINE SULFATE @ 5MCG/ML @ AMPUL (ML) |
| HEXOPRENALINE SULFATE 0.1MG AEROSOL W/ADAPTER (GM) |
| HEXOPRENALINE SULFATE 0.5MG TABLET |
| HEXOPRENALINE SULFATE 1MG TABLET |
| HEXOPRENALINE SULFATE 2.5MCG/ML AMPUL (ML) |
| HEXOPRENALINE SULFATE 5MCG/ML AMPUL (ML) |
| Hexoprenaline Sulfate Inhal Aerosol 0.1 MG/ACT |
| Hexoprenaline Sulfate Inj 2.5 MCG/ML |
| Hexoprenaline Sulfate IV Soln 5 MCG/ML |
| Hexoprenaline Sulfate SL Tab 0.5 MG |
| Hexoprenaline Sulfate Tab 0.5 MG |
| hexopyranoside-cytochrome c oxidoreductase |
| hexopyranoside:cytochrome c oxidoreductase |
| hexopyrronium |
| Hexoral |
| Hexos-2-ulose, 3,4-dideoxy-4-sulfo- |
| hexos-4-ulose |
| Hexosamine |
| Hexosamines |
| Hexosamines [Chemical/Ingredient] |
| Hexosaminidase |
| hexosaminidase (glycosyl hydrolase family 20, catalytic domain) containing |
| Hexosaminidase A |
| hexosaminidase A (alpha polypeptide) |
| hexosaminidase A (alpha polypeptide), human |
| Hexosaminidase A & B Bld-Imp |
| Hexosaminidase A Act Fib-Imp |
| Hexosaminidase A Activating Protein |
| hexosaminidase A activity |
| hexosaminidase A alpha polypeptide, human |
| HEXOSAMINIDASE A AND B DEFIC DIS |
| hexosaminidase a and b deficiency |
| Hexosaminidase A and B Deficiency Disease |
| HEXOSAMINIDASE A DEFIC DIS |
| Hexosaminidase A Deficiencies |
| Hexosaminidase A deficiency |
| Hexosaminidase A Deficiency Disease |
| HEXOSAMINIDASE A DEFICIENCY, ADULT TYPE |
| Hexosaminidase A Determination Reagents |
| Hexosaminidase A Fib-cCnt |
| Hexosaminidase A Fr Amnc |
| Hexosaminidase A fr Ser |
| Hexosaminidase A Fr WBC |
| Hexosaminidase A Ser-cCnc |
| Hexosaminidase A Tiss Ql |
| Hexosaminidase A WBC-cCnc |
| Hexosaminidase A WBC-cCnt |
| Hexosaminidase A WBC-sCnc |
| Hexosaminidase A, alpha Chain |
| Hexosaminidase A, beta Chain |
| Hexosaminidase Activating Factor |
| Hexosaminidase Activator |
| HEXOSAMINIDASE ACTIVATOR DEFICIENCY |
| HEXOSAMINIDASE ACTIVATOR PROTEIN DEFIC DIS |
| Hexosaminidase Activator Protein Deficiency Disease |
| hexosaminidase activity |
| Hexosaminidase alpha Subunit Deficiency (Variant B) |
| Hexosaminidase alpha-Subunit Deficiencies (Variant B) |
| Hexosaminidase alpha-Subunit Deficiency (Variant B) |
| Hexosaminidase B |
| hexosaminidase B (beta polypeptide) |
| hexosaminidase B (beta polypeptide) protein, human |
| HEXOSAMINIDASE B (PARIS), 18-BP INS |
| Hexosaminidase B Fib-cCnt |
| Hexosaminidase B Fr Bld |
| Hexosaminidase B Fr Fib |
| Hexosaminidase B Fr Ser |
| Hexosaminidase B Fr WBC |
| Hexosaminidase B Ser-cCnc |
| Hexosaminidase B WBC-cCnt |
| Hexosaminidase B WBC-sCnc |
| Hexosaminidase B, beta Chain |
| HEXOSAMINIDASE B, HEAT-LABILE POLYMORPHISM, ALA543THR |
| hexosaminidase C |
| Hexosaminidase Deficiencies, Total |
| Hexosaminidase Deficiency, Total |
| Hexosaminidase I Ser-cCnc |
| Hexosaminidase level finding |
| Hexosaminidase measurements |
| Hexosaminidases |
| Hexosaminidases [Chemical/Ingredient] |
| HEXOSAMINIDASES A AND B DEFICIENCY |
| hexosaminoglycan sulfate |
| hexosaminoglycans |
| hexosan |
| hexose |
| hexose 1-phosphate guanylyltransferase activity |
| hexose 1-phosphate nucleotidyltransferase activity |
| hexose 1-phosphate uridyltransferase activity |
| hexose anabolism |
| hexose biosynthesis |
| hexose biosynthetic process |
| hexose bisphosphatase activity |
| hexose breakdown |
| hexose catabolic process |
| hexose catabolism |
| hexose degradation |
| hexose diphosphatase activity |
| hexose formation |
| hexose mediated signaling |
| hexose mediated signalling |
| hexose metabolic process |
| hexose metabolism |
| Hexose Monophosphate Isomerase |
| hexose monophosphate isomerase activity |
| hexose monophosphate pathway |
| Hexose Monophosphate Shunt |
| Hexose Monophosphate Shunts |
| hexose nucleotidylating enzyme activity |
| hexose oxidase |
| hexose oxidase activity |
| hexose phosphatase |
| hexose phosphate dehydrogenase activity |
| hexose phosphate isomerase activity |
| hexose phosphate synthetase |
| hexose phosphate transmembrane transporter activity |
| hexose phosphate transport |
| hexose phosphate:hexose phosphotransferase activity |
| Hexose phosphates |
| Hexose Phosphotransferases, Phosphoenolpyruvate |
| hexose synthesis |
| hexose transmembrane transporter activity |
| hexose transport |
| Hexose Transport Proteins |
| Hexose Transporter |
| hexose transporter 1 protein, Plasmodium falciparum |
| hexose transporter 1 protein, S cerevisiae |
| hexose transporter 15 protein, S cerevisiae |
| hexose transporter 3 protein, S cerevisiae |
| hexose transporter 4 protein, S cerevisiae |
| hexose uniporter activity |
| hexose-1-phosphate guanylyltransferase activity |
| hexose-1-phosphate uridylyltransferase activity |
| hexose-6-phosphate dehydrogenase |
| hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) |
| HEXOSE-6-PHOSPHATE DEHYDROGENASE PRECURSOR |
| hexose-6-phosphate mutarotase, S cerevisiae |
| hexose-6-phosphate phosphohydrolase |
| hexose-phosphate:inorganic phosphate antiporter activity |
| hexose:hydrogen symporter activity |
| hexose:proton symporter |
| Hexosediphosphatase |
| hexosediphosphatase activity |
| HEXOSEDIPHOSPHATASE DEFIC |
| Hexosediphosphatase Deficiencies |
| Hexosediphosphatase Deficiency |
| Hexosediphosphates |
| Hexosediphosphates [Chemical/Ingredient] |
| Hexosephosphate Aminotransferase |
| hexosephosphate aminotransferase activity |
| hexosephosphate isomerase |
| hexosephosphate isomerase activity |
| Hexosephosphate Uridylyltransferase |
| Hexosephosphates |
| Hexosephosphates [Chemical/Ingredient] |
| Hexoses |
| Hexoses [Chemical/Ingredient] |
| Hexostoma |
| Hexostoma thynni |
| Hexostomatidae |
| hexosyltransferase |
| hexosyltransferase activity |
| Hexosyltransferases |
| Hexosyltransferases [Chemical/Ingredient] |
| hexothiocaine |
| Hexouronic Acids |
| HexSiPc |
| hexsyn |
| HEXTAT |
| Hextend |
| Hextend 6% Solution for Injection |
| Hextend 60 MG/ML Injectable Solution |
| Hextend, 6 g/100 mL lactated ringers intravenous solution |
| Hextend, 6 gm/100 ml lactated ringers intravenous solution |
| Hextend, 6 gm/100 ml-0.9% intravenous solution |
| Hextend, 60 mg/mL-LR intravenous solution |
| hexthionine sulfoximine |
| Hextril |
| hexulose-6-phosphate isomerase activity |
| hexulose-6-phosphate synthase |
| hexulose-6-phosphate synthase activity |
| hexulosonic acid 6-phosphate |
| Hexura |
| Hexura picea |
| hexuronate |
| hexuronate (glucuronate/galacturonate) porter activity |
| hexuronate porter activity |
| hexuronate transmembrane transporter activity |
| hexuronate transport |
| hexuronate:cation symporter activity |
| Hexuronic Acids |
| Hexuronic Acids [Chemical/Ingredient] |
| hexuronide transmembrane transporter activity |
| hexuronide transport |
| Hexurono-2-(acetylamino)-2-deoxy-D-gluco-2-(sulfoamino)-2-deoxy-D-glucan, hydrogen sulfate (ester), sodium salt |
| hexuronyl hexosaminoglycan sulfate |
| Hexvix |
| HexvixR |
| hexY protein, Erwinia carotovora |
| hexyl 2,5-dichlorophenylphosphoroamidate |
| hexyl 5-aminolevulinate |
| hexyl acrylate |
| hexyl alcohol |
| Hexyl Alcohols |
| hexyl biphenylacetate |
| hexyl cinnamic aldehyde |
| hexyl cinnamylaldehyde |
| hexyl cyanoacrylate polymer |
| hexyl decanoate |
| hexyl epsilon-aminocaproate |
| hexyl laurate |
| hexyl methacrylate |
| hexyl methyl ether |
| hexyl methyl phthalate |
| hexyl nicotinate |
| hexyl salicylate |
| hexyl vanillate-2-ethoxybenzoic acid |
| hexyl-6-carboxyquinol-4(1H)-one-3-carboxamide |
| hexyl-adenosine 5'-monophosphate-sepharose |
| hexyl-agarose |
| hexyl-alpha,omega-bisdodecyldimethylammonium bromide |
| hexyl-aminolevulinate |
| hexyl-cAMP |
| hexyl-DCP |
| hexyl-insulin monoconjugate 2 |
| hexyladenosine 5'-monophosphate-sepharose |
| hexylamine |
| hexylamine hydrobromide |
| hexylamine hydrochloride |
| hexylcaine |
| hexylcaine 50 MG/ML |
| hexylcaine 50 MG/ML Topical Solution |
| HEXYLCAINE HCL @ 5% @ SOLUTION, NON-ORAL |
| HEXYLCAINE HCL 5% SOLUTION, NON-ORAL |
| HEXYLCAINE HCL 5% TOPICAL SOLUTION, NON-ORAL |
| HEXYLCAINE [email protected]%@[email protected], NON-ORAL |
| hexylcaine hydrochloride |
| hexylcaine Topical Solution |
| hexylchloroformate |
| hexyldecanol |
| hexyldimethylamine oxide |
| hexylene glycol |
| hexylene glycol, titanium(4+) salt |
| hexylene-1,6-bis(dodecyldimethylammonium bromide) |
| hexylglutathione |
| hexylidene-1,6-bis(dimethyloctadecylammonium bromide) |
| hexylidene-1,6-bis(dimethyloctadecylammonium) |
| hexylitaconic acid |
| HEXYLNICOTINATE |
| HEXYLNICOTINATE 20 MG/ML |
| HEXYLNICOTINATE 30 MG/ML |
| HEXYLNICOTINATE/AMYL SALICTLAT 3-0.5% CREAM (GRAMS) |
| HEXYLNICOTINATE/AMYL SALICYLATE @ 3-0.5% @ CREAM (GRAMS) |
| HEXYLNICOTINATE/AMYL SALICYLATE 3-0.5% CREAM (GRAMS) |
| HEXYLNICOTINATE/ETHYL NICOTINATE/THURFYL SALICYLATE @ 2-2-14% @ CREAM (GRAMS) |
| HEXYLNICOTINATE/ETHYL NICOTINATE/THURFYL SALICYLATE 2-2-14% CREAM (GRAMS) |
| hexyloxirane |
| hexyloxyphenol |
| hexylphosphonic acid diethyl ester |
| hexylpsoralen |
| Hexylresorcinol |
| Hexylresorcinol [Chemical/Ingredient] |
| HEXYLRESORCINOL @ @ LIQUID (ML) |
| HEXYLRESORCINOL @ @ LOZENGE |
| HEXYLRESORCINOL @ 0.1% @ SOLUTION, NON-ORAL |
| HEXYLRESORCINOL @ 2.4MG @ LOZENGE |
| HEXYLRESORCINOL @ 3.5MG @ LOZENGE |
| Hexylresorcinol / laureth-9 Rectal Suppository |
| Hexylresorcinol / laureth-9 Topical Ointment |
| Hexylresorcinol 0.0025 MG/MG |
| Hexylresorcinol 0.0025 MG/MG / laureth-9 0.03 MG/MG Topical Ointment |
| Hexylresorcinol 0.005 MG/MG |
| Hexylresorcinol 0.005 MG/MG / laureth-9 0.08 MG/MG Rectal Suppository |
| HEXYLRESORCINOL 0.1% SOLUTION, NON-ORAL |
| HEXYLRESORCINOL 0.1% Topical liquid |
| HEXYLRESORCINOL 0.1% TOPICAL SOLUTION, NON-ORAL |
| Hexylresorcinol 1 MG |
| Hexylresorcinol 1 MG/ML |
| Hexylresorcinol 1 MG/ML [ST-37] |
| Hexylresorcinol 1 MG/ML Topical Solution |
| Hexylresorcinol 1 MG/ML Topical Solution [ST-37] |
| Hexylresorcinol 1.1 MG |
| Hexylresorcinol 2.4 MG |
| Hexylresorcinol 2.4 MG Lozenge |
| Hexylresorcinol 2.4 MG Mucous Membrane Lozenge/Troche |
| HEXYLRESORCINOL 2.4 MG Oral (systemic) lozenge |
| HEXYLRESORCINOL 2.4MG LOZENGE |
  119 120 121 122 123   |
